Annual Revenue ($)

Cryo-Cell revenue was $31.15 m in FY, 2020

Quarterly Revenue ($)

FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$23.13 m$25.38 m$29.22 m$31.82 m$31.15 m
Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$5.78 m$6.24 m$6.9 m$6.23 m$6.53 m$7.87 m$7.5 m$8.13 m$8.22 m$7.62 m$7.87 m$8.11 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Cryo-Cell revenue breakdown by business segment: 97.4% from Umbilical Cord Blood and Cord Tissue Stem Cell Service and 2.6% from Other

FY, 2019FY, 2018FY, 2017FY, 2016
PrepaCyte CB$172.4 k$104.32 k$442.19 k$350.13 k
Umbilical Cord Blood and Cord Tissue Stem Cell Service$30.99 m$28.82 m$24.94 m$22.78 m
Public Cord Blood Banking$652.2 k$296.3 k

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu